Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RNASE1 | P07998 | 1/20 | 0.63 |
| ▸ | TK1 | P04183 | 6/20 | 0.52 |
| ▸ | TK2 | O00142 | 3/20 | 0.51 |
| ▸ | LMNA | P02545 | 2/20 | 0.51 |
| ▸ | TSHR | P16473 | 2/20 | 0.51 |
| ▸ | ALB | P02768 | 1/20 | 0.51 |
| ▸ | PKM | P14618 | 1/20 | 0.51 |
| ▸ | BLM | P54132 | 1/20 | 0.51 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.51 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31355237 | 0.89 | RNASE1 (0.72) | RNASE1TK1TK2 | |
| SCHEMBL9017662 | 0.87 | RNASE1 (0.68) | RNASE1TK1TK2ALBPKM | |
| SCHEMBL9017697 | 0.85 | RNASE1 (0.61) | RNASE1TK1TK2 | |
| SCHEMBL9017714 | 0.85 | RNASE1 (0.63) | RNASE1TK1TK2 | |
| SCHEMBL8657317 | 0.83 | POLB (0.54) | TK1 | |
| SCHEMBL8657316 | 0.83 | POLB (0.54) | TK1 | |
| SCHEMBL9017759 | 0.81 | RNASE1 (0.58) | RNASE1TK1LMNATSHRALB | |
| SCHEMBL2056647 | 0.81 | RNASE1 (0.69) | RNASE1TK1LMNATSHRALB | |
| SCHEMBL9017703 | 0.81 | RNASE1 (0.69) | RNASE1TK1TK2LMNATSHR | |
| SCHEMBL12718428 | 0.81 | RNASE1 (0.67) | RNASE1TK1TK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0611075-B1 | Modified oligodeoxyribonucleotides, their preparation and their therapeutic use | SANKYO CO (JP) | 1996-12-18 | — | — | EP | disclosed |
| EP-0611075-A1 | Modified oligodeoxyribonucleotides, their preparation and their therapeutic use | SANKYO COMPANY LIMITED (JP) | 1994-08-17 | — | — | EP | disclosed |